insights_auto
Kwa nini EDIT imepungua kwa 3.27%?
Fahamu zaidichevron_right
EDIT:NASDAQ
Editas Medicine Inc
US$ 2.10
arrow_downward
-3.27%(-0.071) Siku 1
16 Nov, 09:37:39 GMT -5 · USD
search
Alama zote
| Alama | Bei | Tofauti | Tofauti ya asilimia |
|---|
insights_autoInatayarisha maarifa maarufu ya EDIT...
Fungua
US$ 2.10
Juu
US$ 2.12
Chini
US$ 2.06
Mtaji wa soko
323.96M
Wastani wa kiasi cha mauzo
2.44M
Kiasi cha mauzo ya hisa
elfu 8.95
Juu kwa wiki 52
US$ 3.94
Chini kwa wiki 52
US$ 1.66
EPS
-US$ 0.62
Beta
2.09
Hisa za wawekezaji
154.34M
Idadi ya wafanyakazi
87
Fungua
US$ 2.10
Juu
US$ 2.12
Chini
US$ 2.06
Mtaji wa soko
323.96M
Wastani wa kiasi cha mauzo
2.44M
Kiasi cha mauzo ya hisa
elfu 8.95
Juu kwa wiki 52
US$ 3.94
Chini kwa wiki 52
US$ 1.66
EPS
-US$ 0.62
Beta
2.09
Hisa za wawekezaji
154.34M
Idadi ya wafanyakazi
87
Habari
Kutoka kwenye vyanzo vya wavuti na washirika wa habari
ChartMill
·
saa 1 iliyopita
S&P 500 Premarket Losers on Nov. 16, 2026: COIN, LITE, COHR
Kitco
·
saa 1 iliyopita
S&P 500, Nasdaq futures fall ahead of Nvidia earnings, Anthropic IPO
Crypto News
·
saa 3 zilizopita
Bitget launches rToken Earn for tokenized S&P 500, Nasdaq-100 ETFs
FXEmpire
·
saa 1 iliyopita
Why The S&P 500 Could Fall 63% – And Still Only Be Fairly Valued
Wasifu
Editas Medicine, Inc., is a clinical-stage biotechnology company that is developing therapies for rare diseases using CRISPR gene editing technology. Editas Medicine headquarters is located in Cambridge, Massachusetts with additional facilities in Boulder, Colorado. Wikipedia
Kuhusu Editas Medicine Inc
Afisa Mkuu Mtendaji (CEO)-
Wafanyakazi87
LilianzishwaNov 2013
Makao makuu-
SektaHealth Care
Sekta-
Tovutieditasmedicine.com